Capricor Therapeutics, Inc. (CAPR): Price and Financial Metrics

CAPR POWR Grades

• CAPR scores best on the Sentiment dimension, with a Sentiment rank ahead of 69.74% of US stocks.
• The strongest trend for CAPR is in Value, which has been heading down over the past 179 days.
• CAPR ranks lowest in Momentum; there it ranks in the 8th percentile.

CAPR Stock Summary

• Capricor Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 6.73% of US listed stocks.
• CAPR's price/sales ratio is 338.33; that's higher than the P/S ratio of 98.91% of US stocks.
• With a year-over-year growth in debt of 802.17%, Capricor Therapeutics Inc's debt growth rate surpasses 98.18% of about US stocks.
• Stocks that are quantitatively similar to CAPR, based on their financial statements, market capitalization, and price volatility, are STRO, YMAB, BCDA, ASND, and TARS.
• Visit CAPR's SEC page to see the company's official filings. To visit the company's web site, go to www.capricor.com.

CAPR Valuation Summary

• CAPR's price/earnings ratio is -6.4; this is 117.53% lower than that of the median Healthcare stock.
• CAPR's price/earnings ratio has moved up 5.7 over the prior 174 months.
• CAPR's EV/EBIT ratio has moved up 8.9 over the prior 174 months.

Below are key valuation metrics over time for CAPR.

CAPR Growth Metrics

The 4 year cash and equivalents growth rate now stands at 12.33%.
• Its 5 year cash and equivalents growth rate is now at 12.33%.
• The 3 year net cashflow from operations growth rate now stands at 6.91%.

CAPR's revenue has moved down $4,699,937 over the prior 70 months.

The table below shows CAPR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	0.244898	-16.80932	-20.02252
2021-09-30	0.302728	-15.02414	-18.00993
2021-06-30	0.319591	-14.66378	-17.98824
2021-03-31	0.165373	-12.16602	-16.72413
2020-12-31	0.31025	-10.05481	-13.65703
2020-09-30	0.47452	-7.997445	-10.94851

CAPR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CAPR has a Quality Grade of D, ranking ahead of 11.34% of graded US stocks.
• CAPR's asset turnover comes in at 0.008 -- ranking 401st of 682 Pharmaceutical Products stocks.
• DRNA, MYMD, and PCRX are the stocks whose asset turnover ratios are most correlated with CAPR.

The table below shows CAPR's key quality metrics over time.